Some Investors May Be Willing To Look Past Brenntag's (ETR:BNR) Soft Earnings

Soft earnings didn't appear to concern Brenntag SE's (ETR:BNR) shareholders over the last week. We think that the softer headline numbers might be getting counterbalanced by some positive underlying factors.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.XTRA:BNR Earnings and Revenue History May 21st 2026

The Impact Of Unusual Items On Profit

For anyone who wants to understand Brenntag's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by €137m due to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's hardly a surprise given these line items are considered unusual. Assuming those unusual expenses don't come up again, we'd therefore expect Brenntag to produce a higher profit next year, all else being equal.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Brenntag's Profit Performance

Because unusual items detracted from Brenntag's earnings over the last year, you could argue that we can expect an improved result in the current quarter. Because of this, we think Brenntag's earnings potential is at least as good as it seems, and maybe even better! On the other hand, its EPS actually shrunk in the last twelve months. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. If you want to do dive deeper into Brenntag, you'd also look into what risks it is currently facing. Every company has risks, and we've spotted 4 warning signs for Brenntag you should know about.

This note has only looked at a single factor that sheds light on the nature of Brenntag's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.

Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

View Comments